Clevudine
- Generic Name
- Clevudine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C10H13FN2O5
- CAS Number
- 163252-36-6
- Unique Ingredient Identifier
- IN51MVP5F1
- Indication
用于慢性乙型肝炎(简称乙肝)的治疗。
- Associated Conditions
- Viral Hepatitis B
- Associated Therapies
- -
Safety and Antiviral Activity of Clevudine in Patients Infected With Hepatitis B Virus
Phase 2
Terminated
- Conditions
- First Posted Date
- 2006-03-21
- Last Posted Date
- 2006-04-12
- Lead Sponsor
- Bukwang Pharmaceutical
- Target Recruit Count
- 120
- Registration Number
- NCT00305019
- Locations
- 🇰🇷
Seoul National University, Yeongeon-dong, Jongno-Gu, Seoul, Korea, Republic of
🇰🇷Yongdong Severance Hospital, Dogok-dong, Kangnam-Gu, Seoul, Korea, Republic of
🇰🇷Korea University Guro Hospital, Guro-dong, Guro-ku, Seoul, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath